- Report
- December 2024
- 90 Pages
Global
From €2184EUR$2,400USD£1,873GBP
- Report
- October 2024
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 188 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- September 2024
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 307 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2023
- 342 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- February 2024
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- June 2023
- 119 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2022
- 124 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- March 2023
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- May 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- October 2024
- 101 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2021
- 747 Pages
Global
From €3640EUR$4,000USD£3,121GBP
- Report
- June 2022
- 210 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- March 2024
- 496 Pages
- Book
- February 2020
- 202 Pages

Radioimmunotherapy (RIT) is a type of immunotherapy used to treat immune disorders. It combines the targeting ability of monoclonal antibodies with the cell-killing power of radiation. RIT works by attaching a radioactive isotope to an antibody that binds to a specific antigen on the surface of cancer cells. The radiation then kills the cancer cells, while leaving healthy cells unharmed. RIT is used to treat a variety of immune disorders, including lymphoma, leukemia, and multiple myeloma. It is also used to treat some solid tumors, such as neuroblastoma and melanoma.
RIT is a relatively new form of treatment, and is still being studied for its effectiveness and safety. It is often used in combination with other treatments, such as chemotherapy and radiation therapy.
Some companies in the RIT market include Advanced Accelerator Applications, Immunomedics, and Endocyte. Show Less Read more